{
  "content": "46.\nMart√≠nez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, Fernandez-Gomez JM, Santos JM, Camacho C.Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.Am J Cardiol.2000;86(9):950-95311053705Google ScholarCrossref\n47.\nJoseph AP, Ward MR.A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.Ann Emerg Med.2000;36(1):1-910874228Google ScholarCrossref\n48.\nBlanc JJ, Voinov C, Maarek M.PARSIFAL Study Group.Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation.Am J Cardiol.1999;84(9):1029-103210569658Google ScholarCrossref\n49.",
  "source": "https://jamanetwork.com/journals/jama/fullarticle/208819",
  "chunk_id": "c4adabdb-f816-40ed-b514-6cf3d123eaba",
  "similarity_score": 0.3085917830467224,
  "query": "amiodarone efficacy cardioversion atrial fibrillation success rate beta-blockers metoprolol propranolol carvedilol",
  "rank": 46,
  "title": "Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications",
  "authors": "Patricia Vassallo, Richard G. Trohman",
  "year": "2007",
  "journal": "JAMA",
  "reference": "Vassallo, P., & Trohman, R. G. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA, 298(11), 1312-1322. https://doi.org/10.1001/jama.298.11.1312",
  "doi": "10.1001/jama.298.11.1312",
  "chunk_index": 141,
  "total_chunks": 177,
  "retrieved_at": "2025-07-24T21:57:47.296349"
}